MX2009003755A - Cristal novedoso de (s)-(+)-2-(2-clorofenil)-2-hidroxietil carbamato. - Google Patents
Cristal novedoso de (s)-(+)-2-(2-clorofenil)-2-hidroxietil carbamato.Info
- Publication number
- MX2009003755A MX2009003755A MX2009003755A MX2009003755A MX2009003755A MX 2009003755 A MX2009003755 A MX 2009003755A MX 2009003755 A MX2009003755 A MX 2009003755A MX 2009003755 A MX2009003755 A MX 2009003755A MX 2009003755 A MX2009003755 A MX 2009003755A
- Authority
- MX
- Mexico
- Prior art keywords
- chlorophenyl
- hydroxy
- ethyl carbamate
- novel crystal
- crystal
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/16—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/12—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Abstract
La presente invención se relaciona con un cristal novedoso de (S)-(+)-2-(2-clorofenil)-2-hidroxietil carbamato, composiciones farmacéuticas que comprenden este cristal y métodos para elaborar y utilizar este cristal.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US82839206P | 2006-10-06 | 2006-10-06 | |
PCT/US2007/021502 WO2008045391A2 (en) | 2006-10-06 | 2007-10-05 | Novel crystal of (s)-(+)-2-(2-chlorophenyl)-2-hydroxy-ethyl carbamate |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009003755A true MX2009003755A (es) | 2009-07-10 |
Family
ID=39283405
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009003755A MX2009003755A (es) | 2006-10-06 | 2007-10-05 | Cristal novedoso de (s)-(+)-2-(2-clorofenil)-2-hidroxietil carbamato. |
Country Status (19)
Country | Link |
---|---|
US (1) | US7632963B2 (es) |
EP (1) | EP2076258A4 (es) |
JP (1) | JP2010505856A (es) |
KR (1) | KR20090076958A (es) |
CN (1) | CN101657195A (es) |
AU (1) | AU2007307029A1 (es) |
BR (1) | BRPI0718131A2 (es) |
CA (1) | CA2665573A1 (es) |
CO (1) | CO6180504A2 (es) |
CR (1) | CR10764A (es) |
EA (1) | EA200970355A1 (es) |
GT (1) | GT200900076A (es) |
IL (1) | IL198016A0 (es) |
MX (1) | MX2009003755A (es) |
NI (1) | NI200900050A (es) |
NO (1) | NO20091771L (es) |
SV (1) | SV2009003211A (es) |
WO (1) | WO2008045391A2 (es) |
ZA (1) | ZA200903095B (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8609849B1 (en) | 2010-11-30 | 2013-12-17 | Fox Chase Chemical Diversity Center, Inc. | Hydroxylated sulfamides exhibiting neuroprotective action and their method of use |
CN104136413B (zh) * | 2011-12-27 | 2016-10-26 | 比皮艾思药物研发有限公司 | 用于预防或治疗癫痫症的苯基氨基甲酸酯化合物 |
CA3227793A1 (en) * | 2021-08-05 | 2023-02-09 | Yong Moon Choi | Phenylcarbamate crystalline form and method for manufacturing the same |
KR102399807B1 (ko) * | 2021-08-05 | 2022-05-20 | (주)바이오팜솔루션즈 | 페닐카바메이트 결정형 및 이의 제조 방법 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5698588A (en) * | 1996-01-16 | 1997-12-16 | Yukong Limited | Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol |
EP1129712A4 (en) * | 1999-09-10 | 2002-11-05 | Dainippon Ink & Chemicals | PREPARATIONS OF QUINOLINONE DERIVATIVES AND THEIR PRODUCTION METHOD |
HUP0303264A3 (en) * | 2001-02-27 | 2012-07-30 | Ortho Mcneil Pharm Inc | Carbamate compounds for use in preventing and treating neurodegenerative disorders |
AU2002358806B2 (en) * | 2001-12-21 | 2009-09-10 | Sk Biopharmaceuticals Co., Ltd. | Process for preparing 2-(substituted phenyl)-2-hydroxy-ethyl carbamates |
JP5043429B2 (ja) * | 2003-08-18 | 2012-10-10 | ハー・ルンドベック・アクチエゼルスカベット | トランス−4−((1r,3s)−6−クロロ−3−フェニルインダン−1−イル)−1,2,2−トリメチルピペラジンのコハク酸塩およびマロン酸塩、および薬剤としての使用方法 |
NZ553813A (en) * | 2004-09-16 | 2010-09-30 | Janssen Pharmaceutica Nv | Use of 2-phenyl-1, 2-ethanediol-(DI) carbamates for treating epileptogenesis and epilepsy |
US20070021500A1 (en) * | 2005-07-12 | 2007-01-25 | Twyman Roy E | Methods for neuroprotection |
-
2007
- 2007-10-05 EA EA200970355A patent/EA200970355A1/ru unknown
- 2007-10-05 AU AU2007307029A patent/AU2007307029A1/en not_active Abandoned
- 2007-10-05 MX MX2009003755A patent/MX2009003755A/es active IP Right Grant
- 2007-10-05 US US11/867,803 patent/US7632963B2/en not_active Expired - Fee Related
- 2007-10-05 CN CN200780045483A patent/CN101657195A/zh active Pending
- 2007-10-05 BR BRPI0718131-0A2A patent/BRPI0718131A2/pt not_active IP Right Cessation
- 2007-10-05 CA CA002665573A patent/CA2665573A1/en not_active Abandoned
- 2007-10-05 KR KR1020097009191A patent/KR20090076958A/ko not_active Application Discontinuation
- 2007-10-05 EP EP07839353A patent/EP2076258A4/en not_active Withdrawn
- 2007-10-05 WO PCT/US2007/021502 patent/WO2008045391A2/en active Application Filing
- 2007-10-05 JP JP2009531487A patent/JP2010505856A/ja not_active Withdrawn
-
2009
- 2009-04-03 NI NI200900050A patent/NI200900050A/es unknown
- 2009-04-03 SV SV2009003211A patent/SV2009003211A/es not_active Application Discontinuation
- 2009-04-05 IL IL198016A patent/IL198016A0/en unknown
- 2009-04-06 GT GT200900076A patent/GT200900076A/es unknown
- 2009-04-07 CO CO09035814A patent/CO6180504A2/es not_active Application Discontinuation
- 2009-05-05 CR CR10764A patent/CR10764A/es not_active Application Discontinuation
- 2009-05-05 NO NO20091771A patent/NO20091771L/no not_active Application Discontinuation
- 2009-05-05 ZA ZA200903095A patent/ZA200903095B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
WO2008045391A3 (en) | 2008-06-12 |
CA2665573A1 (en) | 2008-04-17 |
US7632963B2 (en) | 2009-12-15 |
EP2076258A4 (en) | 2011-09-28 |
CR10764A (es) | 2009-09-14 |
NO20091771L (no) | 2009-05-05 |
WO2008045391A2 (en) | 2008-04-17 |
CO6180504A2 (es) | 2010-07-19 |
KR20090076958A (ko) | 2009-07-13 |
CN101657195A (zh) | 2010-02-24 |
NI200900050A (es) | 2010-02-01 |
GT200900076A (es) | 2010-05-18 |
EP2076258A2 (en) | 2009-07-08 |
IL198016A0 (en) | 2009-12-24 |
ZA200903095B (en) | 2010-07-28 |
BRPI0718131A2 (pt) | 2013-11-05 |
EA200970355A1 (ru) | 2009-12-30 |
JP2010505856A (ja) | 2010-02-25 |
AU2007307029A1 (en) | 2008-04-17 |
US20080085930A1 (en) | 2008-04-10 |
SV2009003211A (es) | 2009-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2007008790A (es) | Pirazolo piridinas sustituidas, composiciones que las contienen, metodo de produccion de las mismas, y su uso. | |
WO2008064353A3 (en) | 7,8-saturated-4,5-epoxy-morphinanium analogs | |
NO20090175L (no) | Stabile laquinimod sammensetninger | |
UA97502C2 (ru) | Кристаллическая твердая основа разагилина | |
WO2008036642A3 (en) | N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase | |
WO2008036653A3 (en) | N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase | |
ZA200801394B (en) | Novel sulphonylpyrroles as inhibitors of HDAC S novel sulphonylpyrroles | |
WO2006136357A3 (de) | Kristalline modifikationen des pyraclostrobins | |
WO2010048358A3 (en) | Ethoxyphenylmethyl inhibitors of sglt2 | |
TW200730518A (en) | Crystalline forms of docetaxel and processes for their preparation | |
ECSP088854A (es) | Moduladores bencimidazolicos de vr1 | |
WO2006078886A3 (en) | Compounds and compositions as wnt signaling pathway modulators | |
TW200738649A (en) | Calcilytic compounds | |
IL198145A0 (en) | Phenylalkylamino carbamate compositions | |
HK1133642A1 (en) | Azaadamantane ester and carbamate derivatives and methods of use thereof | |
TW200728310A (en) | Process for the preparation of ferri-succinylcasein | |
WO2009100275A3 (en) | Compositions and devices | |
WO2007067784A3 (en) | Liposomal compositions | |
TW200613308A (en) | Cyclobutanetetracarboxylate compound and preparation method thereof | |
MX2009003755A (es) | Cristal novedoso de (s)-(+)-2-(2-clorofenil)-2-hidroxietil carbamato. | |
WO2009132119A3 (en) | Substituted oxazolidinones | |
WO2006110185A3 (en) | Antiinfective lipopeptides | |
WO2010059639A3 (en) | Hydroxyadamantyl inhibitors of dipeptidylpeptidase iv | |
WO2006062901A3 (en) | Silacycle compounds and methods of use thereof | |
MX2009003930A (es) | Novedoso cristal de (s)-(+)-2-(2-clorofenil)-2-hidroxi-etil carbamato. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |